Differential requirements for β-catenin in murine prostate cancer originating from basal versus luminal cells

Journal of Pathology

Volumn 236, Issue 3, 2015, Pages 290-301

  Lu, Tsai Ling ^a   Chen, Chun Ming ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Taiwan Mouse Clinic National Phenotyping Centre   (Taiwan)

Author keywords

cell lineages; mouse model; prostate cancer; Pten

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BASAL CELL; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; ANIMAL; CELL LINEAGE; DEFICIENCY; DISEASE COURSE; EPITHELIUM CELL; GENETICS; HUMAN; METABOLISM; MUTATION; PATHOLOGY; PROSTATE TUMOR; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; DISEASE PROGRESSION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MALE; MICE; MUTATION; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84930474502     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4521     Document Type: Article

References (51)

1. Shen MM, Abate-Shen C,. Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev 2010; 24: 1967-2000.
2. Goldstein AS, Stoyanova T, Witte ON,. Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells. Mol Oncol 2010; 4: 385-396.
3. Mirosevich J, Bentel J, Zeps N, et al., Androgen receptor expression of proliferating basal and luminal cells in adult murine ventral prostate. J Endocrinol 1999; 162: 341-350.
4. English HF, Santen RJ, Isaacs JT,. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 1987; 11: 229-242.
5. Verhagen APM, Ramaekers FCS, Aalders TW, et al., Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 1992; 52: 6182-6187.
6. Bonkhoff H, Stein U, Remberger K,. Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers. Hum Pathol 1994; 25: 42-46.
7. Leong KG, Wang BE, Johnson L, et al., Generation of a prostate from a single adult stem cell. Nature 2008; 456: 804-808.
8. Lawson DA, Xin L, Lukacs RU, et al., Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci USA 2007; 104: 181-186.
9. Goldstein AS, Lawson DA, Cheng D, et al., Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci USA 2008; 105: 20882-20887.
10. high stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res 2009; 69: 8555-8562.
11. Lu T-L, Huang Y-F, You L-R, et al., Conditionally ablated Pten in prostate basal cells promotes basal-to-luminal differentiation and causes invasive prostate cancer in mice. Am J Pathol 2013; 182: 975-991.
12. Wang ZA, Mitrofanova A, Bergren SK, et al., Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat Cell Biol 2013; 15: 274-283.
13. Choi N, Zhang B, Zhang L, et al., Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell 2012; 21: 253-265.
14. Liu J, Pascal LE, Isharwal S, et al., Regenerated luminal epithelial cells are derived from pre-existing luminal epithelial cells in adult mouse prostate. Mol Endocrinol 2011; 25: 1849-1857.
15. Wang X, Kruithof-de Julio M, Economides KD, et al., A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009; 461: 495-500.
16. Wang Zhu A, Toivanen R, Bergren Sarah K, et al., Luminal cells are favored as the cell of origin for prostate cancer. Cell Rep 2014; 8: 1339-1346.
17. Gaisa NT, Graham TA, McDonald SAC, et al., Clonal architecture of human prostatic epithelium in benign and malignant conditions. J Pathol 2011; 225: 172-180.
18. Blackwood JK, Williamson SC, Greaves LC, et al., In situ lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells. J Pathol 2011; 225: 181-188.
19. Drake JM, Graham NA, Stoyanova T, et al., Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression. Proc Natl Acad Sci USA 2012; 109: 1643-1648.
20. Lawson DA, Zong Y, Memarzadeh S, et al., Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci USA 2010; 107: 2610-2615.
21. Goldstein AS, Huang J, Guo C, et al., Identification of a cell of origin for human prostate cancer. Science 2010; 329: 568-571.
22. Xin L, Teitell MA, Lawson DA, et al., Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor. Proc Natl Acad Sci USA 2006; 103: 7789-7794.
23. Stoyanova T, Cooper AR, Drake JM, et al., Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells. Proc Natl Acad Sci USA 2013; 110: 20111-20116.
24. Chesire DR, Isaacs WB,. β-Catenin signaling in prostate cancer: an early perspective. Endocr Relat Cancer 2003; 10: 537-560.
25. Bierie B, Nozawa M, Renou JP, et al., Activation of β-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation. Oncogene 2003; 22: 3875-3887.
26. Gounari F, Signoretti S, Bronson R, et al., Stabilization of β-catenin induces lesions reminiscent of prostatic intraepithelial neoplasia, but terminal squamous transdifferentiation of other secretory epithelia. Oncogene 2002; 21: 4099-4107.
27. Nagamani SC, Zhang F, Shchelochkov OA, et al., Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment. J Med Genet 2009; 46: 825-833.
28. Francis JC, Thomsen MK, Taketo MM, et al., β-Catenin is required for prostate development and cooperates with Pten loss to drive invasive carcinoma. PLoS Genet 2013; 9: e1003180.
29. Brault V, Moore R, Kutsch S, et al., Inactivation of the β-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 2001; 128: 1253-1264.
30. Muzumdar MD, Tasic B, Miyamichi K, et al., A global double-fluorescent Cre reporter mouse. Genesis 2007; 45: 593-605.
31. Moriyama A, Kii I, Sunabori T, et al., GFP transgenic mice reveal active canonical Wnt signal in neonatal brain and in adult liver and spleen. Genesis 2007; 45: 90-100.
32. Lukacs RU, Goldstein AS, Lawson DA, et al., Isolation, cultivation and characterization of adult murine prostate stem cells. Nat Protoc 2010; 5: 702-713.
33. Yu YR, You LR, Yan YT, et al., Role of OVCA1/DPH1 in craniofacial abnormalities of Miller-Dieker syndrome. Hum Mol Genet 2014; 23: 5579-5596.
34. Mani SA, Guo W, Liao MJ, et al., The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
35. Morel AP, Hinkal GW, Thomas C, et al., EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice. PLoS Genet 2012; 8: e1002723.
36. Lukacs RU, Memarzadeh S, Wu H, et al., Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell 2010; 7: 682-693.
37. Vander Griend DJ, Karthaus WL, Dalrymple S, et al., The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 2008; 68: 9703-9711.
38. Trerotola M, Rathore S, Goel HL, et al., CD133, Trop-2 and α2β1 integrin surface receptors as markers of putative human prostate cancer stem cells. Am J Transl Res 2010; 2: 135-144.
39. Burger PE, Xiong X, Coetzee S, et al., Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci USA 2005; 102: 7180-7185.
40. Xin L, Lawson DA, Witte ON,. The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 2005; 102: 6942-6947.
41. Bisson I, Prowse DM,. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res 2009; 19: 683-697.
42. Carreras Puigvert J, von Stechow L, Siddappa R, et al., Systems biology approach identifies the kinase Csnk1a1 as a regulator of the DNA damage response in embryonic stem cells. Sci Signal 2013; 6: ra5.
43. Magee JA, Chang LW, Stormo GD, et al., Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element. Endocrinology 2006; 147: 590-598.
44. Mostaghel EA, Page ST, Lin DW, et al., Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer. Cancer Res 2007; 67: 5033-5041.
45. Mulholland DJ, Tran LM, Li Y, et al., Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth. Cancer Cell 2011; 19: 792-804.
46. Holowacz T, Huelsken J, Dufort D, et al., Neural stem cells are increased after loss of β-catenin, but neural progenitors undergo cell death. Eur J Neurosci 2011; 33: 1366-1375.
47. Cobas M, Wilson A, Ernst B, et al., β-Catenin is dispensable for hematopoiesis and lymphopoiesis. J Exp Med 2004; 199: 221-229.
48. Zhao C, Blum J, Chen A, et al., Loss of β-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 2007; 12: 528-541.
49. Jeannet Gg, Scheller M, Scarpellino Lo, et al., Long-term, multilineage hematopoiesis occurs in the combined absence of β-catenin and γ-catenin. Blood 2008; 111: 142-149.
50. Wang Y, Krivtsov AV, Sinha AU, et al., The Wnt/β-catenin pathway is required for the development of leukemia stem cells in AML. Science 2010; 327: 1650-1653.
51. Malanchi I, Peinado H, Kassen D, et al., Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling. Nature 2008; 452: 650-653.